This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Santé Cannabis, a pioneer in medical cannabis in Québéc , has partnered with Spectrum Therapeutics, the medical division of Canopy Growth (TSX: WEED) (NYSE: CGC) to launch the Prescriber Training Program, designed to aid physicians and patients, announced today at the new Santé Cannabis clinic and research centre in Montréal.
“I’m excited to join the Travelers Institute for a data-driven discussion,” said Wasserman. With new census data, control of Congress on a knife-edge and redistricting just ahead, there couldn’t be a better time to dive into the numbers.”. Programs include: Sept. Media: Sperry Mylott, 860.277.5075. 22 – “High Risk?
Cannabiz Media recently spoke with Tony Repanich, President and Chief Operating Officer at Shield Compliance, to learn more about how he and his team use the Cannabiz Media License Database to support their business development, data intelligence, and license verification processes. View original article.
Cannabiz Media recently spoke with Kevin Hart, CEO and Founder of Green Check Verified, to learn more about how he and his team use the Cannabiz Media License Database to support their research, sales, and growth initiatives. Why Does Green Check Verified Subscribe to the Cannabiz Media License Database? Just do your homework.
Cannabiz Media recently spoke with David Rula, founding partner of Gold Leaf Packaging, to learn more about how he and his team use the Cannabiz Media License Database to support their sales and business growth initiatives. Why Does Gold Leaf Packaging Subscribe to the Cannabiz Media License Database? View original article.
Cannabiz Media recently spoke with Robert Mohr, Cannabis Channel Manager, and Haley Hayes, Sales Executive, from PeopleGuru to learn more about how their team uses the Cannabiz Media License Database to support its sales and business growth initiatives. Why Does PeopleGuru Subscribe to the Cannabiz Media License Database?
(CSE: MXT) (OTCQB: MXTTF) aims to address these problems by pairing biometric interviews with brainwave data to create a proprietary mental health reference database. Using machine learning algorithms and qualified practitioner input, the company is leveraging that data to build tools that deliver digital diagnostic opinions.
Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands. Reduce costs.
The approach will build the integrity of the licensed market – one that relies on science and data. “In We work with cultivators and dispensaries who truly care about the quality of their products and understand the value of reliable and meaningful data in the eyes of the modern consumer.
On March 8, the FDA granted the accelerated approval of Roche’s programmed cell death protein 1 (PD-1) inhibitor Tecentriq in combination with Abraxane (protein-bound paclitaxel) for the treatment of locally advanced or metastatic triple-negative breast cancer (TNBC). To gain access to our latest press releases: GlobalData Media Centre.
LAS VEGAS, NV (March 4, 2021) – Cannabis Conference (August 24-26, 2021, at the Paris Las Vegas Hotel & Casino) today announces its education program, which includes 45+ sessions within four education tracks that will provide actionable takeaways about the most pressing issues plant-touching businesses currently face in the cannabis industry.
WHAT: During their panel discussion, “ Promoting Healthy Eating ,” experts will review the latest consumer trends data regarding diet and shopping patterns, the role of plant-based foods in category plans and why it is so important for retailers to take a leadership role when it comes to health and nutrition. . . WHEN: Sept. Beauty. . .
Spotlight PA sought that data to better understand the impact of the agency’s unusual and controversial decision to endorse cannabis as a treatment option for opioid use disorder. The newsroom specifically requested aggregate data — information that would not identify individual patients.
Report shows Maine’s adult use program is ahead of pace set by other states, to serve as foundation for expansion of stakeholder outreach by OCP . The findings of this report serve as an excellent baseline for us to measure the continued evolution of our programs,” added Gundersen. “OCP
Bottom-line, it’s extremely difficult to stay competitive in any industry today without a customer relationship management (CRM) system in place, and the data proves it. Research shows using a CRM software, like the Cannabiz Media License Database, can boost sales conversion rates by as much as 300%. Improve Sales and Marketing ROI.
The results from this study will provide validating data on the efficacy of the Company’s products in reducing pain and improving joint mobility in dogs. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.
Companies today need a more viable business model , one that transcends geography, mobility challenges faced by certain demographics including seniors, improves patient engagement and creates real time data scalability. Cognizance VCT enables the generation of cost-effective quality data with ethical consent, on par with academic studies.
Data from Marijuana Business Daily’s 2021 Annual Marijuana Business Factbook puts the growth potential of the cannabis industry over the next several years into perspective. According to the data in the 2021 Annual Marijuana Business Factbook , U.S. Cannabis Sales Growth. cannabis sales will climb to $48.4 Vermont : Up to $14 million.
Hemp Production Remains Relatively Unscathed, Supported by Demand and Federal Programs. 3] Hemp growers, like other farmers, are further supported by federal programs. 3] Hemp growers, like other farmers, are further supported by federal programs.
In addition to the Psychedelic Invest Podcast, the company plans to unveil a handful of content programs throughout the rest of 2022. “We’re going to continue to build infrastructure around reliable data that fuels high-quality educational content. .” Media Contact: Durée & Company, Inc.
Love it or hate it, social media can be a powerful tool for education and data collection. Miyabe Shields, PhD are using platforms like TikTok and Instagram to help followers understand cannabis pharmacology, while gathering unique data on their experiences with it. A Synergistic Relationship.
Indeed, McEvoy found, few such retailers maintain adequate privacy management programs or document privacy policies, despite obligations under B.C.’s The findings came in the course of a compliance review of 30 retailers based on media stories and enquiries about the sector’s collection, use and disclosure of personal information.
Michigan and Massachusetts continue to make strong showings as their programs continue to grow. . Ed Keating is a co-founder of Cannabiz Media and oversees the company’s data research and government relations efforts. Active licenses are up 9.2% since the beginning of the year. 43% of the new licenses were in Oklahoma.
Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. What if most of it is not based on the level of scientific certainty that cannabis marketing teams and media outlets would have us believe? Recent data suggest the US science knowledge is about the global average.
The FDA is aware of media reports of delta-8 THC products getting consumers “high.” NPDS data do not reflect the entire universe of exposures to a particular substance as additional exposures may go unreported to PCCs; accordingly, NPDS data should not be construed to represent the complete incidence of U.S.
Santé Cannabis, a pioneer in medical cannabis in Québéc , has partnered with Spectrum Therapeutics, the medical division of Canopy Growth (TSX: WEED) (NYSE: CGC) to launch the Prescriber Training Program, designed to aid physicians and patients, announced today at the new Santé Cannabis clinic and research centre in Montréal.
Retail licenses for Oklahoma’s medical cannabis program declined 8% in 2020, the first contraction for the open-license market since MMJ sales began in 2018. market for dispensary licenses grew 12%, with other large, mature markets such as California, Colorado and Oregon continuing to add retail licenses in 2020, Cannabiz Media reported.
After months of development, my partner and I built and successfully launched the beta for our cannabis data-analytics software, Jade Insights. It’s a software platform that helps cannabis businesses augment their process by providing insights for data-backed decision-making. ” DR. G. MALIK BURNETT. ” JOHN KAGIA.
Former President Bill Clinton has apparently been hearing a lot about the therapeutic potential of CBD products for pain management lately, and, according to a now-deleted media report, said at a recent conference appearance that broad interest in the topic should spur regulators to develop standards for the cannabinoid. Ganjapreneur report.
BRAMPTON, Ontario–(BUSINESS WIRE)–DATA Communications Management Corp. Unregistered shareholders, guests and media will be able to listen and view online via the live webcast available at the same link. ABOUT DATA COMMUNICATIONS MANAGEMENT CORP. Additional information relating to DATA Communications Management Corp.
This data set integrates with Farm Journal’s Farm Reach database to provide agribusinesses, government agencies, investors and suppliers with unparalleled insights into this exciting growth market. Over the past 50 years, Farm Journal has become the trusted partner in agricultural data and today manages more than 4.1
As we begin design of Phase 2 of our buildout, we will add more square feet to our facilities to continue to meet the demand of the medical program in West Virginia.”. Media Contacts Lindsay Wilson. media@col-care.com. “Our ability to begin operations solidifies our position as a leader in the state. About Columbia Care.
The awards program will identify and recognize the best employers in cannabis cultivation and dispensary markets, continuing the recognition the media brands debuted two years ago. Be legally licensed to cultivate or sell cannabis for medical and/or adult-use under a state regulatory framework (or federal program if in Canada).
The awards program will identify and recognize the best employers in cannabis cultivation and dispensary markets, continuing the recognition the media brands debuted two years ago. Be legally licensed to cultivate or sell cannabis for medical and/or adult-use under a state regulatory framework (or federal program if in Canada).
Active research includes applications of machine learning and data mining as a member of the University of Alberta computational psychiatry group. For media inquiries, please contact Crystal Quast at: Bullseye Corporate. For more information, please contact the Company at: Entheon Biomedical Corp. Joseph Cullen, Investor Relations.
The Australian Criminal Intelligence Commission (ACIC) on Monday released the 15th report of its National Wastewater Drug Monitoring Program. tonnes of methylamphetamine, cocaine, MDMA and heroin was consumed in 2020-21, the fifth year of the Program. An estimated 15.7 The drop of approximately 4.7 An estimated 15.7
The current public policies in local and state cannabis ordinance and equity programs may enhance racial disparities if they follow the pattern of exclusion and criminalization that encompass past policies promoted as beneficial to African Americans but uphold racial capitalistic practices. Authored By: By Dr. Ayoka Nurse.
CB2 Insights, at its core, is a research and technology company, offering a suite of data and technology solutions as a full service clinical CRO, specializing in Phase III and Phase IV, post-marketing, observational and experimental trials in a range of therapeutic areas for stakeholders worldwide. Requirements.
In furtherance of its program, the Company filed US Provisional Patent Application No. “Entheon is proud to be making significant strides in its Entheon IQ™ program,” says Timothy Ko, Chief Executive Officer of Entheon. US Provisional Patent Filed. ” In Vivo Toxicity Assays Completed. joe@entheonbiomedical.com.
When you select a state on NCIA’s map, you can click to view more comprehensive details about the state’s legal cannabis program. The data is compiled by NCIA’s employees and comes from sources like BDS Analytics and Arcview Market Research – two recognized companies in the cannabis industry. License types. Licensing fees.
s (CSE: MXT) (OTC: MXTTF) SHAMAN and YMI programs apply machine learning to high-resolution health records to better diagnose mental health disorders. Despite the tremendous promise of psychedelics, there are no large-scale standardized clinical trials or data sources that clinicians can use to guide their patient decisions.
In particular, we see significant market opportunity for nabiximols in several indications in the US and will be progressing multiple late stage clinical programs in 2020.”. Nabiximols (known as “Sativex” outside US) in the US: Commence pivotal clinical program in initial target indication of spasticity associated with Multiple Sclerosis.
Within this blog post, we have identified the statements included in the Analytical Cannabis article that Medicinal Genomics knows to be false, those that are true, as well as supplemental data on our position on each specific issue. The FDA program is known as the Genome Trakr network and the CDCs program is known as Pulsenet.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content